TMED1 Protein, Human (HEK293, His)

Customer Review

Based on 1 Customer Validation

The TMED1 protein may facilitate vesicular protein trafficking in the early secretory pathway, acting as a cargo receptor on the luminal side to incorporate secretory cargo into transport vesicles. It is involved in the formation of the vesicle shell on the cytoplasmic side and positively affects IL-33-mediated IL-8 and IL-6 production by interacting with IL1RL1. TMED1 Protein, Human (HEK293, His) is the recombinant human-derived TMED1 protein, expressed by HEK293 , with C-10*His labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: HEK293
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

The TMED1 protein may facilitate vesicular protein trafficking in the early secretory pathway, acting as a cargo receptor on the luminal side to incorporate secretory cargo into transport vesicles. It is involved in the formation of the vesicle shell on the cytoplasmic side and positively affects IL-33-mediated IL-8 and IL-6 production by interacting with IL1RL1. TMED1 Protein, Human (HEK293, His) is the recombinant human-derived TMED1 protein, expressed by HEK293 , with C-10*His labeled tag.

Background

The TMED1 protein potentially plays a role in vesicular protein trafficking, particularly in the early secretory pathway. It may act as a cargo receptor on the lumenal side to facilitate the incorporation of secretory cargo molecules into transport vesicles, and it is also implicated in vesicle coat formation on the cytoplasmic side. Additionally, TMED1 has been shown to have a positive influence on IL-33-mediated IL-8 and IL-6 production by interacting with the interleukin-33 receptor IL1RL1. Furthermore, it is involved in the modulation of innate immune signaling through the cGAS-STING pathway via its interaction with RNF26. TMED1 forms homodimers in the endoplasmic reticulum, endoplasmic reticulum-Golgi intermediate compartment, and cis-Golgi network. It interacts with IL1RL1 and RNF26, with the latter interaction being particularly important for modulating innate immune signaling through the cGAS-STING pathway.

Verified Bioactivity

Immobilized Human TMED1 at 10 μg/mL (100 μL/well) can bind Biotinylated ST2 protein. The ED50 for this effect is 79.64 ng/mL, corresponding to a specific activity is 1.26×10^4 Unit/mg.

MCE Validation Data

  • Purity - SDS-PAGE

    Purity - SDS-PAGE

    ≥ 95%, as determined by reducing SDS-PAGE.

  • Bioactivity - ELISA

    Bioactivity - ELISA

    Immobilized Human TMED1 at 10 μg/mL (100 μL/well) can bind Biotinylated ST2 protein. The ED50 for this effect is 79.64 ng/mL, corresponding to a specific activity is 1.26×104 Unit/mg.

Technical Parameters

  • Species Human
  • Source HEK293
  • Tag C-10*His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • TMED1 (A24-N194)
      Accession # Q13445
    • 10*His
    • C-term
  • Protein Length

    Extracellular Domain

  • Synonyms

    TMED1; P24 Family Protein Gamma-1; Transmembrane P24 Trafficking Protein 1; MGC1270; IL1RL1LG; ST2L; P24gamma1; Tp24; Il1rl1l; Transmembrane Emp24 Domain Containing 1; P24g1; Interleukin 1 Receptor-Like 1 Ligand; Transmembrane Emp24 Protein Transport Doma

  • AA Sequence

    AGPPPIQDGEFTFLLPAGRKQCFYQSAPANASLETEYQVIGGAGLDVDFTLESPQGVLLVSESRKADGVHTVEPTEAGDYKLCFDNSFSTISEKLVFFELIFDSLQDDEEVEGWAEAVEPEEMLDVKMEDIKESIETMRTRLERSIQMLTLLRAFEARDRNLQEGNLERVN

  • Predicted Molecular Mass

    20.6 kDa

  • Molecular Weight

    Approximately 28 kDa, based on SDS-PAGE under reducing conditions.

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder.

Formulation

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00